Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00736528 · ClinicalTrials.gov registry record · Phase 1
A Phase I, Multiple Dose Study of PF-04447943 in Healthy Elderly Volunteers
A Phase 1 study, sponsored by Pfizer.
- Terminated
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT00736528 is a Phase 1 study that was terminated before completion, run by Pfizer. The registered enrollment target is 10 participants.
The verdict
NCT00736528, a Phase 1 study, was terminated before completion, sponsored by Pfizer.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
To describe the safety, tolerability and pharmacokinetics of PF-04447943 after administration of multiple, ascending, oral doses to healthy elderly subjects.
Interventions
- DRUG Placebo
- DRUG PF-04447943
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2008-08 |
| Est. Completion | 2008-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00736528
The ClinicalTrials.gov registry entry for NCT00736528 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00736528 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00736528 about?
NCT00736528 is a clinical study titled "A Phase I, Multiple Dose Study of PF-04447943 in Healthy Elderly Volunteers". To describe the safety, tolerability and pharmacokinetics of PF-04447943 after administration of multiple, ascending, oral doses to healthy elderly subjects.
What is the current status of trial NCT00736528?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2008-08. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00736528?
The interventions under investigation include: Placebo (DRUG), PF-04447943 (DRUG).
Who is sponsoring clinical trial NCT00736528?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.